Intellectual Property India Publishes Patent Application for Method For Preparing Hyaluronic Acid-Mediated Chitosan-Coated Mogroside-V-Melphalan Nanoconjugates For Cd44-Targeted Ovarian Cancer Therapy

MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202611100238 A) filed by Upes on August 19, 2026, for Method For Preparing Hyaluronic Acid-Mediated Chitosan-Coated Mogroside-V-Melphalan Nanoconjugates For Cd44-Targeted Ovarian Cancer Therapy.

Inventors include Meghna Patial; Jyoti Rajput; Dr. Dhruv Kumar; and Dr. Vineet Kumar.

The application for the patent was published on September 25, 2026, under issue no. 39/2026.

Abstract: The present invention discloses a method (100) for preparing a hyaluronic acid mediated chitosan-coated Mogroside-V-Melphalan nanoconjugate for CD44-targeted ovarian cancer therapy. The method comprises preparing an organic phase comprising 10 mg of a Mogroside-V-Melphala...